Yale Endometrial Stem Cell Expert Joins Medistem’s Scientific Advisory Board

| Share

Medistem Inc. announced the appointment of Dr. Hugh S. Taylor to its Scientific Advisory Board. Dr. Taylor is the first scientist to identify the bone marrow origin of endometrial tissue, and performed independent experiments demonstrating that endometrial stem cells are capable of treating diabetes and Parkinson’s Disease in animal models.

Dr. Taylor is Professor of Obstetrics, Gynecology, and Reproductive Sciences; Section Chief, Reproductive Endocrinology and Infertility; Director, Yale Center for Endometrium and Endometriosis and Director of the Yale Center for Reproductive Biology.

“Dr. Taylor has literally defined the field of endometrial stem cells. His fundamental discovery of the bone marrow origin of endometrial cells in humans was one of the major forces behind the now growing field of endometrial stem cell research,” said Thomas Ichim, CEO of Medistem. “We strongly believe that Dr. Taylor’s deep scientific understanding of biological mechanisms occurring in the endometrium will serve as a foundation for our clinical development programs.”

Medistem is the first company to obtain regulatory approvals by the FDA and international regulators for using endometrial derived stem cells, the Endometrial Regenerative Cell (ERC), for the experimental treatment of patients. It appears that one of the major functions of the Endometrial Regenerative Cell in the body is to produce new blood vessels, a process that occurs every month before menstruation. Medistem is focused on harnessing this natural function of the Endometrial Regenerative Cell to produce new blood vessels in the limbs and hearts of patients with poor circulation.

“I am honored to join the Medistem Team, which has a consistent track record of rapid clinical development while concurrently performing in-depth mechanistic analysis behind their products,” said Dr. Taylor. “We are eager to take the lessons learned from our animal models and work with the Medistem team to translate them into new medicines.”

from http://medisteminc.com/2011/yale-endometrial-stem-cell-expert-joins-medistems-scientific-advisory-board/

Maybe you can find something interesting in the following sponsored links:

Incoming search terms:

2011 findings on endometreosis, medistem enzyme, stem cell retinitis 2012.

Share to Facebook Share to Twitter Stumble It Email This More...
Related pages on the web
  • When Will Auto Makers Get it? Kia Motors must think the American Consumer is an Idiot I watch way too much tv, and I recently I have been seeing a commercial lately for the Kia Forte which has intrigued me: This commercial piqued my interest because it announces that a $14,000 car has both Satellite Radio...
  • Cell Phone Plans: Choose The Best Deal Cell phones have evolved to be one of the most important parts of life. Most businesses require their employees to have a cell phone. Even individuals need cell phones in going about their daily lives. This is why acquiring this...
  • Facts about Weight and Weight Loss Here are some little known facts about your weight, and how to lose it. - The difference between people who are thin and those who are obese is not how many fat cells they have, but rather the size of...
  • Books: Get Your Motivation Back! With January over, many people will be either be well on the way to making their new years resolutions or have already ditched them. If you're part of the first group, good for you! You deserve many kudos for sticking...
  • Is Cell Phone Insurance Worth It? Over the Weekend I had an “incident” where I dropped my new HTC Hero with Google.  Considering I am writing a post on Cell Phone insurance, you know all did not end well as I bobbled it and watched it land on its glass...
Blog Traffic Exchange Related articles on this site

0 Responses to “Yale Endometrial Stem Cell Expert Joins Medistem’s Scientific Advisory Board”


  1. No Comments

Leave a Reply